The Weekly Recap 9/12/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure new funding, announce regulatory milestones, and much more on the road to LSI USA ’26 in Dana Point (March 17–21).

CustomSurg

Announced that OrthoPlanner™, a surgeon-designed digital tool that streamlines pre-operative fracture planning, received FDA clearance for all fracture anatomies. Accessible on smartphones and PCs, the platform enables faster, more precise trauma surgery with no additional hardware or setup required.

Gleamer

Received the Special Jury Prize at the EY Entrepreneur of the Year awards in recognition of its mission to bring trustworthy AI into radiology. Gleamer’s medical-grade AI solutions are designed to support diagnostic accuracy and workflow efficiency to improve care for millions of patients worldwide.

Madison Scientific

Raised $10M in an oversubscribed seed round to accelerate development of the SmartShunt™ Hydrocephalus Management System. The financing reflects strong investor confidence in Madison Scientific’s mission to bring innovation to a historically underserved and high-need market.

MY01

Welcomed LSI Alumni Joe Kiani, founder of Masimo, as an investor and board member to support the continued expansion of its Continuous Perfusion Sensing Technology (CPST) platform. Kiani’s leadership in patient monitoring aligns with MY01’s mission to transform trauma care and deliver earlier, data-driven diagnosis of limb perfusion injuries.

Navigation Sciences

Expanded its Scientific Advisory Board with the addition of three leading thoracic surgeons, Drs. Brian Burt, Brian Mitzman, and Jeffrey Velotta, to support early clinical adoption of the NaviSci™ System. Their expertise will guide clinical workflow design, user interface development, and site selection for initial trials.

Positrigo

Appointed Jerome Descheirder as Global Chief Commercial Officer to lead global sales and commercial strategy, while Stefan Bircher transitions into the new role of Chief Business Development and Marketing Officer. The expanded leadership team will support Positrigo’s accelerating growth and broaden market adoption of its NeuroLF PET brain imaging system.


This blog is originally published here: https://www.lifesciencemarketresearch.com/insights/the-weekly-recap-91225-lsi-alumni-achievements-driving-medtech-and-healthtech-forward 

Comments

Post a Comment

Popular posts from this blog

Cover Story: A Page from Ray Cohen’s Playbook: Scaling, Exiting, and Winning in Medtech

With four decades of company-building, IPOs, boardroom leadership, and monumental exits behind him, Raymond W. Cohen has become one of medtech’s most successful operators. But behind the financial wins — including the recent back-to-back $3.7 billion Axonics and $600 million SoniVie acquisitions by Boston Scientific — is a deeper story of Cohen’s contrarian, full-transparency, people-centered, no-BS approach to leadership and strategy. “People crave inspired, authentic, and transparent leadership that thinks big and acts boldly. They want to be enrolled in a vision of what is possible, and be recognized and compensated for creating measurable results, not be fed a bunch of platitudes.” A quote that is classic  Ray Cohen  — blunt, unapologetic, no-nonsense, and grounded in hard-won experience. With more than four decades in medtech, Cohen has done what many aspire to — build, lead, scale, and sell high-stakes, successful ventures with precision and zero fluff. Known for his no-...
Read more

The Weekly Recap 6/13/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni secure over $63M in new funds, receive FDA 510(k) clearances, announce an acquisition, and much more as we wind down   LSI Asia  ’25 in Singapore and gear up for  LSI Europe  ’25 in London (September 7–11). Accelus Received FDA 510(k) clearance for the FlareHawk Interbody Fusion System to be safely subjected to MRI scanning in certain conditions. The clearance supports Accelus’s commitment to safe, high-performance spinal solutions and expands imaging options for patients with FlareHawk implants. Aortyx Raised $16M to advance its bioresorbable aortic patch toward first-in-human trials. The funding supports continued development of Aortyx’s minimally invasive, tissue-regenerating solution for aortic dissection and positions the company for clinical entry within two years. Atraverse Medical Closed $29.4M in follow-on financing to scale U.S. commercialization of HOTW...
Read more

Medtech in 2025: Key Insights from Q1 Earnings

  As we venture into Q2 of 2025, the medtech industry continues to navigate challenges while remaining on a positive growth trajectory. The early earnings reports from major medtech companies provide valuable insights into how the sector is performing and where it is heading. Despite the pressures of ongoing macroeconomic uncertainty, the first quarter of 2025 shows a sector that’s resilient, with many companies reporting strong growth across their key divisions. For more information visit here:  https://www.slideshare.net/slideshow/medtech-in-2025-key-insights-from-q1-earnings/279045324
Read more